Navigation Links
New consensus on work-related asthma
Date:9/23/2008

In a new consensus statement, the American College of Chest Physicians offers guidance on the diagnosis and treatment of work-related asthma (WRA), a chronic respiratory condition that includes occupational asthma and work-exacerbated asthma (WEA) and affects as many as 25 percent of adults with asthma. Published as a supplement to the September issue of CHEST, the consensus statement, updated from 1995, places new emphasis on

  1. preventive measures, including better control of exposures;
  2. the need for a combination of diagnostic testing; and
  3. the importance of obtaining a full medical and occupational history in patients with suspected WRA.

The statement also places greater consideration on the diagnosis and management of WEA, which is preexisting or concurrent asthma that is worsened by work-related conditions. Developed by an expert panel of specialists in allergy, pulmonary medicine, and occupational medicine, the consensus statement provides supplemental materials, including a worker/workplace fact sheet and physician flow sheets to help physicians and other health-care providers diagnose and manage WRA. For more information related to the ACCP consensus statement on work-related asthma, visit www.chestjournal.org.


'/>"/>

Contact: Jennifer Stawarz
jstawarz@chestnet.org
847-498-8306
American College of Chest Physicians
Source:Eurekalert

0

GOOD

Page: 1

Related biology technology :

1. Expert Consensus Panel Recommendation for Incorporating Lp-PLA2 Testing into Cardiovascular Disease Risk Assessment Guidelines
2. International Wound Care Experts, Medline Announce Pressure Ulcer Prevention Consensus Paper
3. Video: ASMANEX(R) TWISTHALER(R) 110 MCG (Mometasone Furoate Inhalation Powder) is Now Available Nationwide for the Maintenance Treatment of Asthma in Children Ages 4 to 11
4. New Patient Satisfaction Study With budesonide/formoterol Combination Therapy and fluticasone/salmeterol Combination Therapy in Adults With Asthma
5. Asthma Uncontrolled in More Than 40 Percent of Adults With the Disease, New Landmark Survey Shows
6. Asthma Patients Not Adequately Controlled on ICS Alone More Likely to Benefit From Advair(R) Than Doubling the Dose of ICS
7. Apieron, Inc. Announces FDA Clearance of the Insight(TM) eNO System to Assist Physicians with Patient Asthma Management
8. Allergy Standards LTD to Attend 2008 American Academy of Allergy, Asthma and Immunology Conference
9. FDA Grants Market Clearance to Aerocrine Inc.s NIOX MINO(R): a New Hand-Held Device to Measure Airway Inflammation in Asthma
10. Drug Reduces Airway Mucus in Preclinical Asthma Model
11. AIM-Quoted Verona Pharma Progresses Anti-Asthma Drug Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... SAN MARINO, Calif. , May 23, 2013 ... announces today a strategic alliance with DAK Renewable ... increase the corn oil yield. VG Energy is ... Inc. (OTC Pink: VGLS). VG Energy,s ... pathways to increase the oil yield in plants, ...
(Date:5/23/2013)... 23, 2013 Virobay, Inc. today announced that ... reached an important milestone, as Virobay has now initiated ... selective cathepsin S inhibitor.   The first ... placebo-controlled study designed to evaluate the safety, tolerability, pharmacokinetics ... adults. "The initiation of this Phase 1 ...
(Date:5/23/2013)... On April 19th the Center for Disease ... the growing antibiotic resistant bacteria that may be lurking ... study were released late last month showing higher antibiotic ... years. For those suffering from bacteria driven acne, Probiotic ... in food, may eventually help breed acne causing bacteria. ...
(Date:5/23/2013)... , May 23, 2013 Northwest Biotherapeutics (NASDAQ: ... developing DCVax ® personalized immune therapies for solid ... exhibit at this year,s American Society Of Clinical Oncology ... highlight its leadership role in immune therapy.  ... annual meeting is the pre-eminent conference focused on clinical ...
Breaking Biology Technology:VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 2VG Energy Enters into a Strategic Alliance with DAK Renewable Research for LipidMax Field Trials 3Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3
... Expression Genetics, Inc.,(EGEN) announced today that ... selected as one of the Top 10 ... strategic partnering. The selection was made by,an ... leading,provider of business information products and services ...
... Development Efforts, SALT LAKE CITY, Sept. 5 ... development of molecular diagnostic and motion preserving,technologies in ... Ross has,joined the executive management team as the ... this new role, Ross will oversee Axial Biotech,s ...
... Ind., Sept. 4 Zimmer Holdings, Inc.,(NYSE: ZMH ... have,agreed to acquire the Abbott Spine business from Abbott ... to fund the purchase price,from cash on hand and ... expected to close in the fourth quarter of 2008. ...
Cached Biology Technology:Expression Genetics' EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover 2Expression Genetics' EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover 3Axial Biotech appoints new Vice President of Strategic Initiatives 2Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology 2Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology 3Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology 4
(Date:5/22/2013)... investigators also conclude that the 20 percent reduction ... (LDCT) versus chest X-ray (CXR) screening previously reported ... experienced screening centers in the United States. , ... their patients about the benefits and risks of ... the New England Journal of Medicine ...
(Date:5/22/2013)... engineers must join together in a major new effort ... crisis in providing Earth,s people with clean water that ... of a comment article in the current edition of ... of the American Chemical Society (ACS), the world,s largest ... Sedlak, Ph.D., and Jerald L. Schnoor, Ph.D., explain that ...
(Date:5/22/2013)... discovery of potential environmental and human health effects ... each year has led scientists to recommend stronger ... of lithium-ion (Li-ion) battery materials. That,s the conclusion ... Environmental Science & Technology . , Oladele ... batteries have become mainstays for powering everything from ...
Breaking Biology News(10 mins):NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3
... forests that add the most new growth each year -- ... Survey (USGS) study published in a recent issue of the ... forests will respond to ongoing and future environmental changes. , ... world¹s most productive forests may be those likely to respond ...
... DuPont polymer derived from a biological source, has been ... China Central Television (CCTV) as "Most Visionary Innovation" at ... DuPontTM Sorona® will receive the 2005 "New ... Global Plastics and Environmental Conference, sponsored by the Society ...
... core cellular mechanisms of sleep, researchers at University of ... a single gene mutation that has a powerful effect ... In its normal state, the Drosophila (fruit fly) gene, ... flow of potassium into cells, a process that critically ...
Cached Biology News:Live fast, die young true for forests too 2DuPont's first biologically derived polymer receives global recognition 2Wisconsin researchers identify sleep gene 2Wisconsin researchers identify sleep gene 3Wisconsin researchers identify sleep gene 4
Mouse Axl MAb (Clone 175128)...
Mouse GDF-8 Propeptide Affinity Purified Polyclonal Ab...
... Allen (1995) This book contains ... on current issues relating to the aetiology ... advances have been made recently which greatly ... include molecular neuropathology through clinical and diagnostic ...
One-step, microplate or cuvet, colorimetric, linear detection range 0.1 mg/dL to 100 mg/dL. Procedure: 20 min....
Biology Products: